PHGE
$0.38
Biomx
($.04)
(10.21%)
PHGE
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.12)
Revenue:  N/A
Monday
Aug 14
6:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PHGE reports earnings?
Beat
Meet
Miss

Where is PHGE's stock price going from here?
Up
Flat
Down
Stock chart of PHGE
Analysts
Summary of analysts' recommendations for PHGE
Score
Grade
Pivots
Resistance
$0.48
$0.45
$0.41

$0.38

Support
$0.34
$0.31
$0.28
Tweet
Growth
Description
BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel.